Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Orthotolidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 10/20 | 0.94 |
| ▸ | TDP1 | Q9NUW8 | 9/20 | 0.94 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.94 |
| ▸ | TSHR | P16473 | 5/20 | 0.94 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 3/20 | 0.46 |
| ▸ | S100B | P04271 | 1/20 | 0.45 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Orthotolidine SCHEMBL3466480 | 1.00 | CYP3A4 (0.94) | CYP3A4TDP1ALDH1A1TSHRMEN1 | |
| Orthotolidine SCHEMBL38664709 | 1.00 | CYP3A4 (0.94) | CYP3A4TDP1ALDH1A1TSHRMEN1 | |
| Orthotolidine SCHEMBL864763 | 0.97 | CYP3A4 (0.90) | CYP3A4TDP1ALDH1A1TSHRMEN1 | |
| Orthotolidine SCHEMBL29386552 | 0.97 | CYP3A4 (1.00) | CYP3A4TDP1ALDH1A1TSHRMEN1 | |
| Orthotolidine SCHEMBL49414 | 0.97 | CYP3A4 (1.00) | CYP3A4TDP1ALDH1A1TSHRMEN1 | |
| Orthotolidine SCHEMBL29365329 | 0.97 | CYP3A4 (1.00) | CYP3A4TDP1ALDH1A1TSHRMEN1 | |
| Orthotolidine SCHEMBL11189493 | 0.94 | CYP3A4 (0.94) | CYP3A4TDP1ALDH1A1TSHRMEN1 | |
| SCHEMBL8954009 | 0.94 | CYP3A4 (0.94) | CYP3A4TDP1ALDH1A1TSHRMEN1 | |
| Orthotolidine SCHEMBL20547383 | 0.94 | CYP3A4 (0.94) | CYP3A4TDP1ALDH1A1TSHRMEN1 | |
| Orthotolidine SCHEMBL22129692 | 0.94 | CYP3A4 (0.94) | CYP3A4TDP1ALDH1A1TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2799118-B1 | FIRE EXTINGUISHING COMPOSITION CONTAINING TRANSITION METAL COMPOUND | XIAN WESTPEACE FIRE TECH CO LTD (CN) | 2019-07-10 | — | — | EP | claimed |
| US-9717939-B2 | Fire extinguishing composition containing transition metal compound | XI'AN WESTPEACE FIRE TECHNOLOGY CO., LTD (CN) | 2017-08-01 | — | — | US | claimed |
| US-20150190664-A1 | FIRE EXTINGUISHING COMPOSITION CONTAINING TRANSITION METAL COMPOUND | XI'AN J&R FIRE FIGHTING EQUIPMENT CO., LTD. (CN) | 2015-07-09 | — | — | US | claimed |
| EP-2799118-A1 | FIRE EXTINGUISHING COMPOSITION CONTAINING TRANSITION METAL COMPOUND | Xi'an J&R Fire Fighting Equipment Co., Ltd. (CN) | 2014-11-05 | — | — | EP | claimed |
| US-20130146439-A1 | PHOTO-INDUCED REDUCTION-OXIDATION CHEMISTRY OF CARBON NANOTUBES | ROSTOVTSEV VSEVOLOD (US) | 2013-06-13 | — | — | US | claimed |
| US-8038853-B2 | Photo-induced reduction-oxidation chemistry of carbon nanotubes | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-10-18 | — | — | US | claimed |
| EP-1274999-B1 | METHOD AND TEST STRIP OF DETECTING OXIDIZING ADULTERANT IN URINE | BRANAN MEDICAL CORP (US) | 2010-11-17 | — | — | EP | claimed |
| US-20080308407-A1 | PHOTO-INDUCED REDUCTION-OXIDATION CHEMISTRY OF CARBON NANOTUBES | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-12-18 | — | — | US | claimed |
| US-6689618-B1 | CONTACTING ALIQUOT OF BODY FLUID WITH DRY TEST STRIP COMPRISING BENZIDINE DERIVATIVE, DETERMINING PRESENCE OF PYRIDINIUM CHLOROCHROMATE OR SODIUM NITRITE BY OBSERVING COLOR CHANGE, IN WHICH DIFFERENT COLOR RESULTS FOR EACH ADULTERANT | BRANAN MEDICAL CORP. | 2004-02-10 | — | — | US | claimed |
| US-20250180952-A1 | PHOTOALIGNING MATERIALS | Rolic Technologies AG (CH) | 2025-06-05 | — | — | US | disclosed |
| EP-4493638-A1 | PHOTOALIGNING MATERIALS | Rolic Technologies AG (CH) | 2025-01-22 | — | — | EP | disclosed |
| CN-118389296-A | Leuconostoc mesenteroides strain and fruiting body cultivation method and application | 河西学院 | 2024-07-26 | — | — | CN | disclosed |
| CN-118027412-A | Photo-alignment material | 罗利克技术有限公司 | 2024-05-14 | — | — | CN | disclosed |
| WO-2023174773-A1 | PHOTOALIGNING MATERIALS | Rolic Technologies AG (CH) | 2023-09-21 | — | — | WO | disclosed |
| US-4483929-A | Liposomes with glycolipid-linked antibodies | LIPOSOME TECHNOLOGY INCORPORATED (US) | 1984-11-20 | — | — | US | disclosed |
| US-4444879-A | Immunoassay with article having support film and immunological counterpart of analyte | SCIENCE RESEARCH CENTER, INC. (US) | 1984-04-24 | — | — | US | disclosed |
| US-4427783-A | Immunoassay of thymosin α1 | HOFFMANN-LA ROCHE INC. (US) | 1984-01-24 | — | — | US | disclosed |
| EP-0046185-A1 | Process for the preparation of substituted 4,4'-diamino-diphenylene | BASF Aktiengesellschaft (DE) | 1982-02-24 | — | — | EP | disclosed |
| EP-0029917-A1 | Indicator composition and test device containing amine oxide | MILES LABORATORIES, INC. (US) | 1981-06-10 | — | — | EP | disclosed |
| EP-0029926-A1 | A composition and a test device based on a benzidine-type indicator for detecting the presence of a constituent in a test sample | MILES LABORATORIES, INC. (US) | 1981-06-10 | — | — | EP | disclosed |